Status:
COMPLETED
SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Collaborating Sponsors:
ETOP IBCSG Partners Foundation
Conditions:
Any Stage of Lung Cancer (Any Histotype)
Any Stage of Malignant Pleural Mesothelioma
Eligibility:
All Genders
18+ years
Brief Summary
SPECTAlung is a program aiming at screening patients with thoracic tumors to identify the molecular characteristics of their disease. The thoracic tumors include lung cancer, malignant pleural mesothe...
Eligibility Criteria
Inclusion
- Pathologically confirmed lung cancer, MPM, thymoma or thymic carcinoma at any stage;
- Mandatory availability of adequate Human Biological Material (HBM): FFPE tissue sample from the primary tumor, recurrent tumor, metastasis, obtained at the time of primary surgery or biopsy; minimal amount requested is detailed in the HBM guidelines; inclusion of samples taken at any recurrence diagnosed during follow-up is strongly encouraged but optional;
- Centrally performed confirmation of tumor tissue adequacy in terms of quality/ quantity for central screening;
- Age ≥ 18 years;
- At least three months life-expectancy;
- Written informed consent according to ICH/GCP and national/local regulations.
Exclusion
- Any active malignancy, except pT1-2 prostatic cancer Gleason score \< 6, non melanomatous skin cancer or carcinoma in situ of the cervix, in the 5 years before study entry;
- Active hepatitis B/C or HIV;
- Any secondary malignancy;
- Any severe organ dysfunction or other comorbidities that may prevent the inclusion into clinical trials.
Key Trial Info
Start Date :
May 22 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 12 2021
Estimated Enrollment :
539 Patients enrolled
Trial Details
Trial ID
NCT02214134
Start Date
May 22 2015
End Date
May 12 2021
Last Update
August 17 2025
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet
Brussels, Belgium, 1000
2
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
3
U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium, 3000
4
CHU de Lyon - Hopital Louis Pradel
Lyon, France, 69394